Kobayashi Pharmaceutical Co Ltd 2022 Integrated Report
Company: Kobayashi Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2022
Type: Integrated Report
Pages: 94
The report presents 2022 consolidated net sales of 166,258 million yen and continued net income growth, alongside SBTi certification of its 2030 GHG targets. It also reports CDP scores of B for climate change and water security and C for forests. The ESG section describes updated material issues, environmental initiatives, human-rights work, and Group-level sustainability governance.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.